TRANSITION FROM T CELL PROTECTION TO T CELL ENHANCEMENT DURING TUMOR GROWTH IN AN ALLOGENEIC HOST
- 1 October 1976
- journal article
- research article
- Published by Wolters Kluwer Health in Transplantation
- Vol. 22 (4) , 360-366
- https://doi.org/10.1097/00007890-197610000-00007
Abstract
The cell-mediated immune response of mice toward a lethal allogeneic tumor was investigated during tumor development. The activity of spleen cells from the tumor-bearing mice was studied by transferring them together with 3LL tumor cells into normal C3H/eb recipient mice. The activity depended upon the time interval between inoculation of the tumor and transfer. Spleen cells taken relatively early, 1 week after tumor inoculation, mediated protection against tumor growth. In contrast, spleen cells taken 4 weeks after tumor inoculation markedly enhanced tumor growth. The tumor-enhancing cells, like the tumor-protecting cells, appeared to be T lymphocytes. The enhancing activity could be transferred by extracellular medium prepared by incubating the enhancing T cells. Protecting activity could not be transferred by cell-free medium prepared from the protecting T cells. Both activities were found to exist to a relatively slight degree in populations of spleen cells from normal mice. The transition from T cell protection to T cell enhancement might be a determining factor in the outcome of the host-tumor relationship.This publication has 3 references indexed in Scilit:
- SYNGENEIC METASTATIC TUMOR MODEL IN MICE - NATURAL IMMUNE-RESPONSE OF HOST AND ITS MANIPULATION1976
- Evidence for an Immunological Reaction of the Host Directed Against Its Own Actively Growing Primary Tumor2JNCI Journal of the National Cancer Institute, 1966
- THE AKR THYMIC ANTIGEN AND ITS DISTRIBUTION IN LEUKEMIAS AND NERVOUS TISSUESThe Journal of Experimental Medicine, 1964